Skip to main content
user-generated· regulatory

NHS approves Wegovy pill for obesity treatment by 2027

The NHS will include the oral Wegovy in its obesity treatment guidelines within 12 months of private launch. Political pressure to address obesity and cost-effectiveness data will accelerate approval despite budget constraints.

regulatory · Prediction Market

Implied probability (Yes)
60%
Closes
2027-03-31

More regulatory markets

Browse all regulatory markets →

Loading…